What does GlycoMimetics, Inc. do?

Jun 22 2025 06:31 PM IST
share
Share Via
GlycoMimetics, Inc. is a clinical-stage biotechnology company focused on developing glycomimetic drugs, with a market cap of $8.56 million and a recent net profit loss of $2 million. The company has no dividend yield and significant negative return on equity.
Overview:
GlycoMimetics, Inc. is a clinical-stage biotechnology company focused on the discovery and development of glycomimetic drugs within the Pharmaceuticals & Biotechnology industry, categorized as a micro-cap company. Financial Snapshot: - Most recent Net Profit: -2 Million (Quarterly Results - Mar 2025) - Market-cap: USD 8.56 Million (Micro Cap) Key Metrics: - P/E: NA (Loss Making) - Industry P/E: NA - Dividend Yield: 0.00% - Debt Equity: -1.66 - Return on Equity: -650.50% - Price to Book: 2.54 Contact Details: - Address: 9708 Medical Center Dr, ROCKVILLE MD: 20850-3343 - Tel: 1 240 2431201 - Fax: 1 240 2431018
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is GlycoMimetics, Inc. technically bullish or bearish?
Sep 20 2025 07:36 PM IST
share
Share Via
Is GlycoMimetics, Inc. overvalued or undervalued?
Sep 20 2025 06:11 PM IST
share
Share Via
Is GlycoMimetics, Inc. overvalued or undervalued?
Jun 25 2025 08:46 AM IST
share
Share Via
Is GlycoMimetics, Inc. technically bullish or bearish?
Jun 25 2025 08:39 AM IST
share
Share Via
Who are in the management team of GlycoMimetics, Inc.?
Jun 22 2025 10:25 PM IST
share
Share Via
How big is GlycoMimetics, Inc.?
Jun 22 2025 05:53 PM IST
share
Share Via